Skip to content
Kalpvruksh Markets
Offline Log in

PPLPHARMANSEOffline

PIRAMAL PHARMA · INE0DK501011 · Small Cap · #341
238.63+0.87 (+0.37%)last close · 05 Nov 2026
Prev close
237.76
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹21,343 cr
52-week range · to 05 Nov 2026133.27239.92

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

PPLPHARMA is 1% below its 52-week high, above its 200-day average, ahead of Healthcare by 14.3 pts over 3 months — a Small Cap company, #341 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • above its 20 / 50 / 200-day averages · 1% below its 52-week high
  • ahead of its industry by 14.3 pts over 3 months · rank 4 of 44 in Healthcare · +17.9% vs Nifty 500
  • traded value 4.1× usual · delivery 39% vs 40% usual
  • FPI +1.1 pp · DII −0.1 pp · MF schemes in Sept 2026: 25 bought, 44 cut · no promoter pledge · quarter ended 2026-09-30
  • Sept 2026 quarter: profit +106% year on year · revenue +28%
  • nothing scheduled or restricting

How big is it?

six-month average market cap

Market capitalisation
₹21,343 cr
Rank
#341
Cap band
Small Cap
Nearest cut-off — Mid / Small
−37.58% from ₹34,190 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
1.7×
median 12,37,510
Delivered
20,51,473
Of volume
48%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week+3.4%−2.3 pts—
1 month+19.0%+13.8 pts+14.5 pts
3 months+15.4%+17.9 pts+14.3 pts
6 months+44.5%+43.9 pts+30.3 pts
1 year+18.2%+21.3 pts—

Industry: Healthcare (Nifty 500 classification) · rank 4 of 44 over 3 months. Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
+13.9%
above
vs 50-day average
+13.7%
above
vs 200-day average
+33.8%
above
ATR (14)
5.2%
typical daily range
Volatility
68%
1 month, annualised
Beta
1.13
vs Nifty 500, 1 year
Traded value
4.1×
vs usual
Delivery
39%
usual 40%
From the 52-week high
−0.5%
place in range 99% (0 = at the low)

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters34.9%34.9%34.8% −0.134.8%
FPI29.7%30.2% +0.512.5% −17.713.7% +1.1
Mutual funds14.0%14.1% +0.113.2% −0.912.7% −0.5
Other DII1.7%1.5% −0.21.4% −0.11.7% +0.3
Individuals14.1%13.7% −0.414.5% +0.813.3% −1.3
Others5.7%5.6% −0.123.6% +18.023.9% +0.3

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
none
Of all shares
none
Jun 25 noneSep 25 noneDec 25 noneMar 26 noneJun 26 noneSep 26 none

Holders

Sep 26

All shareholders
4,13,197
Individuals
3,98,749

Indian passive funds’ stake

2026-06-30

Of free float
0.73%
Of all shares
0.48%
Schemes
58
Days to unwind
0.7
at 100% of volume

63,61,925 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
93
58 index · 35 active
Bought more
52
Sold some
14
FundSharesChangeDid
ICICI Pru Small Cap Fund(G)Active+7,47,727+74.8%bought
Bajaj Finserv Flexi Cap Fund-Reg(G)Active+21,47,391+64.0%bought
LIC MF Value Fund-Reg(G)Active+54,335+37.8%bought
Aditya Birla SL Small Cap Fund(G)Active−16,30,438−76.4%sold
HDFC Focused Fund-Reg(G)Active−2,15,17,133−71.3%sold
Motilal Oswal BSE Healthcare ETFIndex−2,172−11.5%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 2692619377−3.0%₹3,257 cr
Aug 269375067−2.1%₹3,487 cr
Jul 26931445186+1.0%₹3,248 cr
Jun 2685444154−3.8%₹2,762 cr
May 2685435233+0.4%₹2,952 cr
Apr 268434697−3.1%₹2,755 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
    28 Oct 2026
  • Scheme / acquisition
    Piramal Pharma Limited has informed the Exchange about Acquisition
    18 Aug 2026
  • Board outcome
    Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
    30 Jul 2026

PPLPHARMA: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Corporate actions

full published history

0 selected
EarlierDividend₹0.14Final16 Jul 202516 Jul 2025
EarlierDividend₹0.11Final12 Jul 202412 Jul 2024
EarlierRights5:46—02 Aug 202302 Aug 2023at ₹81

3 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.